6/15/26 21:06 | 6/12/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Haas Jason | FL | D | | M.d | 206 | 51.56 | 0 | 4 | 408 | 5 | D | | | | | | | | | | | | | | |
6/15/26 21:06 | 6/12/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Haas Jason | FL | D | | S.d | -1,651 | 255.58 | 0 | -6 | -56 | 5 | D | | | | | | | | | | | | | | |
5/11/26 20:32 | 5/8/26 | ODTX | Odyssey Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Haas Jason | MA | O | CFO | P | 20 | 20.00 | 0 | 1 | 2 | 63 | D | | | | | | | | | | | | | | |
11/20/24 17:00 | 11/18/24 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Haas Jason | MA | O | CFO | S | -29 | 0.2103 | 0 | -138 | -100 | 0 | D | | | | | | | | | | | | | | |
11/4/24 17:01 | 10/31/24 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Haas Jason | MA | O | CFO | M.d | 0 | 0.00 | 0 | 19 | 16 | 138 | D | | | | | | | | | | | | | | |
9/12/24 17:00 | 9/10/24 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Haas Jason | MA | O | CFO | P.m | 161 | 1.61 | 0 | 100 | 407 | 125 | D | | | | | | | | | | | | | | |
4/2/24 16:54 | 3/31/24 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Haas Jason | MA | O | CFO | M.d | 0 | 0.00 | 0 | 15 | 166 | 25 | D | | | | | | | | | | | | | | |
11/2/23 16:53 | 10/31/23 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Haas Jason | MA | O | CFO | M.d | 0 | 0.00 | 0 | 19 | | 14 | D | | | | | | | | | | | | | | |
4/4/23 18:57 | 3/31/23 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Haas Jason | MA | O | CFO | M.d | 0 | 0.00 | 0 | 2 | | 1 | D | | | | | | | | | | | | | | |